Palvella Therapeutics, Inc (PVLA)
Healthcare
Biotechnology
139.00 $
-7.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Palvella Therapeutics, Inc (PVLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -46 | -7.7 | -15 | -14 | -11 | -25 | |
| 2.1 | 2.4 | – | – | – | – | |
| – | – | 0.4 | 0.6 | 0.8 | 6.4 | |
| -16 | 31 | 1.6 | -3.1 | -0.2 | 3.8 | |
| 2.7 | 0.9 | 1.0 | 0.0 | 0.0 | 0.0 | |
| 39 | -0.9 | -21 | – | – | – | |
| – | – | – | 0.0 | 78 | 0.0 | |
| 10 | 59 | 9.6 | 5.0 | 87 | -0.7 | |
| 8.2 | 47 | -5.3 | -31 | 76 | -26 | |
| -49 | -8.6 | -15 | -14 | -11 | -25 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.